Suchergebnisse - "Xue, Weisong"

PubPharm (8)

1

Use of patient-derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

enthalten in: Bioengineering & translational medicine | 2023

von Xue, W. | Wang, T. | Yao, J. | +12

2

Cutoff value of IC50 for drug sensitivity in patient-derived tumor organoids in colorectal cancer

enthalten in: iScience | 2023

von Tang, Y. | Wang, T. | Hu, Y. | +13

3

Colorectal cancer organoid drug sensitivity evaluation and prognosis prediction system, method and equipment

enthalten in: Europäisches Patentamt | 2023

von TANG YUTING | YAN JUN | XUE WEISONG | +5

4

Use of patient‐derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

enthalten in: Bioengineering & Translational Medicine | 2023

von Xue, W. | Wang, T. | Yao, J. | +12

5

Prognostic and predictive value of a pathomics signature in gastric cancer

enthalten in: Nature communications | 2022

von Chen, D. | Fu, M. | Chi, L. | +14

6

A novel, simplified, and reproducible porcine model of acute ischemic liver failure with portal vein preservation

enthalten in: Experimental animals | 2022

von Xue, W. | Fu, Y. | Zhang, H. | +7

7

PYY modulates the tumorigenesis and progression of colorectal cancer unveiled by proteomics

enthalten in: American journal of cancer research | 2022

von Jing, F. | Liu, G. | Zhang, R. | +9

8

Progression in bowel dysfunction after sphincter-preserving operation for rectal cancer

enthalten in: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery | 2014

von Xue, W. | Chi, P.

1
[1]